GENIFEM Trial: Postoperative Pain After Total Knee Arthroplasty (TKA)

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

May 25, 2023

Study Completion Date

May 25, 2023

Conditions
AnalgesiaTotal Knee Arthroplasty
Interventions
PROCEDURE

Genicular nerve block-iPACK group

Group 1: Genicular nerve block-iPACK group (performed by anaesthesiologist) Method: Ultrasound and nerve stimulation guided injection Drug: a total of 30 ml of ropivacaine 0,5% (150 mg) will be used

PROCEDURE

Femoral triangle block-iPACK group

Group 2: Femoral triangle block-iPACK group (performed by anaesthesiologist) Method: Ultrasound and nerve stimulation guided injection Drug: a total of 30 ml of ropivacaine 0,5% (150 mg) will be used

PROCEDURE

Local infiltration analgesia

Group 3: LIA (performed by surgeon) Method: Blind injection Drug: a total of 200ml of 0.2% ropivacaine will be used (400mg). Of this, 150ml of ropivacaine 0.2% will be mixed with 1mg of adrenaline.

Trial Locations (1)

3500

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors
lead

Ziekenhuis Oost-Limburg

OTHER